Report : Global Viscosupplementation Market 2016-2020 is a new market research publication announced by Reportstack.
Report Outline: Viscosupplementation is a minimally invasive treatment for knee osteoarthritis. It involves the injection of hyaluronic acid into a knee joint to assist the viscous properties of synovial fluid. The procedure increases the joint’s functioning and reduces pain. Intra-articular viscosupplementation with hyaluronic acid is gaining acceptance as it is a non-invasive procedure compared to knee replacement. It is categorized into three product segments –– single-injection cycle, three-injection cycle, and five-injection cycle.
For detailed report with TOC, please click here Global Viscosupplementation Market 2016-2020
Market Growth: The global Viscosupplementation market is expected to grow at a CAGR of 6.23% during the period 2016-2020.
Key vendors • Sanofi
• Anika Therapeutics
• Seikagaku
• Fidia Farmaceutici
• Ferring Pharmaceuticals
• Anika Therapeutics
• Seikagaku
• Fidia Farmaceutici
• Ferring Pharmaceuticals
Other prominent vendors • Allergan
• Contipro Biotech
• DePuy Synthes
• F. Hoffmann-La Roche
• Galderma
• HTL Biotechnology
• Hyaltech
• Expanscience Laboratoires
• Lifecore Biomedical
• Lipo Chemicals
• Merz Aesthetics
• Mylan
• Nordic Drugs
• Shandong Freda Biochem
• Shanghai Jingfeng Pharmaceutical
• Smith & Nephew
• TEIJIN PHARMA
• Contipro Biotech
• DePuy Synthes
• F. Hoffmann-La Roche
• Galderma
• HTL Biotechnology
• Hyaltech
• Expanscience Laboratoires
• Lifecore Biomedical
• Lipo Chemicals
• Merz Aesthetics
• Mylan
• Nordic Drugs
• Shandong Freda Biochem
• Shanghai Jingfeng Pharmaceutical
• Smith & Nephew
• TEIJIN PHARMA
• TRB Chemedica International
Regions Covered:
• Americas
• APAC
• EMEA
• APAC
• EMEA
Companies Mentioned
Lear Corporation, Johnson Controls, Grammer AG.
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###
No comments:
Post a Comment